Nantahala Capital Management - AVENUE THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of AVENUE THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$1,319,000
+2831.1%
1,453,166
+4710.1%
0.05%
+4500.0%
Q3 2021$45,000
-40.8%
30,2110.0%0.00%
-50.0%
Q2 2021$76,000
-58.5%
30,2110.0%0.00%
-60.0%
Q1 2021$183,000
+1.7%
30,2110.0%0.01%
-16.7%
Q4 2020$180,00030,2110.01%
Other shareholders
AVENUE THERAPEUTICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
Nantahala Capital Management 1,453,166$1,319,0000.05%
EMFO, LLC 24,000$22,0000.02%
B. Riley Wealth Advisors, Inc. 71,338$65,0000.00%
Warberg Asset Management LLC 10,001$9,0000.00%
TWO SIGMA SECURITIES, LLC 20,036$18,0000.00%
NORTHERN TRUST CORP 13,767$13,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 27,230$25,0000.00%
BNP PARIBAS FINANCIAL MARKETS 85$77,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 77,413$70,0000.00%
View complete list of AVENUE THERAPEUTICS INC shareholders